Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DHEA in Veterans with PTSD
NCT03491007Phase 2Terminated
- Sponsor
- VA Office of Research & Development
- Start
- Jul 2019
- Primary completion
- Nov 2020
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 2 trial of dehydroepiandrosterone in post-traumatic stress disorder (PTSD), sponsored by VA Office of Research & Development. Started Jul 2019; status: terminated.
02
Drugs
dehydroepiandrosterone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT03491007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03491007.